Cronos Group

Buy-side

Financial Advisor, June 2021

Cronos Group
Strategic investment in PharmaCann Inc.

Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development.

More Like This

Jan 2024

Recapitalization of Virginia Green

Exclusive Financial Advisor

View Details >
Jun 2023
$50 Million

Acquisition of Operational Infrastructure from Blue Apron Holdings, Inc. (NYSE: APRN)

Exclusive Financial Advisor

View Details >
Mar 2023

Acquisition of Firebirds Wood Fired Grill

Exclusive Financial Advisor

View Details >